June 13, 2013 at 17:51 PM EDT
Dynavax Extends Losses
Dynavax Technologies Corp. (Nasdaq: DVAX) extended its losses by falling 18 cents to close at $1.20 after the Food and Drug Administration requested an additional safety study for its hepatitis B vaccine on Monday.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here